![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Efficacy and Safety of B/F/TAF in Hispanic/Latine Adults With HIV-1 Initiating First-Line Therapy: 5-Year Follow-up From Two Phase 3 Studies
|
|
|
AIDS 2024 July 20-26 Munich
Claudia Martorell1, Olayemi Osiyemi2, Mezgebe Berhe3, Lizette Santiago4, Christopher Rosero5, Fang Fang5, Nathan Unger5, Jason T Hindman5, Moti Ramgopal6
1The Research Institute, Springfield, MA, USA; 2Triple O Research Institute, West Palm Beach, FL, USA; 3North Texas Infectious Diseases Consultants, Dallas, TX, USA; 4HOPE Clinical Research, San Juan, Puerto Rico; 5Gilead Sciences, Inc., Foster City, CA, USA; 6Midway Immunology and Research Center, Fort Pierce, FL, USA
![0730241](../images/073024/073024-17/0730241.gif)
![0730242](../images/073024/073024-17/0730242.gif)
![0730243](../images/073024/073024-17/0730243.gif)
![0730244](../images/073024/073024-17/0730244.gif)
![0730245](../images/073024/073024-17/0730245.gif)
![0730246](../images/073024/073024-17/0730246.gif)
![0730247](../images/073024/073024-17/0730247.gif)
![0730248](../images/073024/073024-17/0730248.gif)
![0730249](../images/073024/073024-17/0730249.gif)
![07302410](../images/073024/073024-17/07302410.gif)
![07302411](../images/073024/073024-17/07302411.gif)
![07302412](../images/073024/073024-17/07302412.gif)
![07302413](../images/073024/073024-17/07302413.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|